2024ASPHO

Advertisement
Patrick DalySickle Cell Disease | April 23, 2024
Dr. Vadivelan shared her study on pituitary and pancreatic iron deposition in patients with SCD at the 2024 ASPHO Conference.
Melissa BadamoSickle Cell Disease | April 18, 2024
The study compared health care resource use and costs of pediatric patients with SCD compared with matched controls.
Patrick DalyAnemia | April 15, 2024
Delaying treatment for SAA until genetic testing for IBMFS may be detrimental in patients with negative workup and history.
Yaw Ansong-Ansongton, MDSickle Cell Disease | April 12, 2024
Dr. Ansong-Ansongton shared what National Minority Health Month and Celebrate Diversity Month mean to him at ASPHO 2024.
Yaw Ansong-Ansongton, MDSickle Cell Disease | April 9, 2024
Dr. Ansong-Ansongton described data on the impact of abnormal mitochondrial retention and cold in red blood cells in SCD.
Erica Mamauag, MDHemophilia | April 9, 2024
Dr. Mamauag details her study on the need for factor VIII infusions in patients with tolerized hemophilia A on emicizumab.
Anjali Sharathkumar, MDAnemia | April 5, 2024
Dr. Sharathkumar shared data from her 2024 ASPHO presentation on romiplostim in children with severe aplastic anemia and MDS.
Zaina Inam, MDSickle Cell Disease | April 5, 2024
The study evaluated transplant outcomes in pediatric patients with SCD who had a history of red blood cell alloimmunization.
Patrick DalySickle Cell Disease | April 4, 2024
A standardized, local TCD supported by central quality review was implemented effectively in resource-constrained settings.
Patrick DalyHematology | March 27, 2024
ASPHO President Caroline Hastings, MD, offers highlights from the 2024 ASPHO conference in Seattle, WA.
Advertisement